Can Sculptra reverse GLP-1-related facial ageing? Experts say yes
New data presented at AMWC Dubai highlights Sculptra’s regenerative effects and its synergy with Restylane to address GLP-1-related facial ageing. Discover expert insights and clinical findings.
Supreme bets on GLP-1 users with SlimFast acquisition
Post Content
GLP-1 drug approvals: A breakdown
As of Oct. 17, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications. The approved indications for brand-name GLP-1s: Bydureon (exenatide) Type 2 diabetes in patients ages 10 years and older Byetta (exenatide) Type 2 diabetes in adults Mounjaro (tirzepatide) Type 2 diabetes […]
How GLP-1 drugs are supercharging the age of precision nutrition
As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop precision nutrition solutions – using AI and functional ingredients to personalise diets and target metabolism more effectively.
The GLP-1 Economy Is Crashing. CVS Ventures Is Quietly Building What Comes Next
As the GLP-1 economy cools, CVS Ventures leads a $25 million round in Knownwell — betting on physician-led obesity care and payer-backed innovation.
Could functional foods replace the need for GLP-1s?
Explore how functional ingredients are challenging GLP-1 drugs in weight management – and what this shift means for food and beverage innovation.
Ozempic for All
An estimated 100 million adult Americans—more than 40 percent of the population—are classified as obese. This is a massive health crisis that will claim many lives over the next decades. As is well known, drugs now exist that can dramatically reduce obesity and its related health risks. But most of the roughly 37 million adult […]
What FEHB changes mean for your 2026 health coverage
<![CDATA[ Most federal employees and retirees will pay much more for health coverage next year; the enrollee share of premium is going up 12.3% on average. OPM cites an aging federal workforce with more chronic conditions and prescription drug usage, including GLP-1 medications prescribed for weight loss, as contributors to the premium increase. How will […]
GLP-1 Weight-loss Drugs May Reduce Alcohol Cravings
Post Content
Novo Secures Cardiovascular Expansion for Semaglutide Pill
Rybelsus can now be used as a primary or secondary prevention pill to lower the risk of major adverse cardiovascular events in at-risk patients with type 2 diabetes.